Emerging role of multikinase inhibitors for refractory thyroid cancer

Thyroid cancer incidence continues to increase, remaining the most common endocrine malignancy. The need for effective systemic therapies combined with high incidence of driver mutations and overexpression of molecular pathways make refractory thyroid cancer an ideal candidate for treatment with nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Cesar A, Arango, Belisario A, Velez, Michel, Raez, Luis E, Santos, Edgardo S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421474/
https://www.ncbi.nlm.nih.gov/pubmed/22904617
http://dx.doi.org/10.2147/BTT.S24465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421474/
https://www.ncbi.nlm.nih.gov/pubmed/22904617
http://dx.doi.org/10.2147/BTT.S24465

Ejemplares similares